Litigation Details for Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2015)
✉ Email this page to a colleague
Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-09-15 |
Court | Court of Appeals for the Federal Circuit | Date Terminated | |
Cause | Assigned To | ||
Jury Demand | Referred To | ||
Patents | 6,228,398; 6,277,384; 6,294,195; 6,340,475; 6,495,155; 6,514,531; 7,276,250; 7,851,482; 8,114,383; 8,192,722; 8,309,060; 8,309,122; 8,329,216 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
Biologic Drugs cited in Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
Details for Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2016-10-05 | 121 | 2008/0318993 Al 12/2008 Ah di ch 6,228,398 Bl 5/2001 Devane et al. … 2008/0318994 Al 12/2008 Ah di ch 6,228,398 Bl 5/2001 Devane et al. 6,228,863 …concerning the patent application that later issued as U.S. Patent No. 8,309,122 (“’122 patent”), one of …proceeding that involves U.S. Patent No. 8,329,216 (“’216 patent”), the other patent at issue …contribution toward patentability of certain claim elements in Endo’s patents. The ‘122 patent was issued from | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |